Hope so for your friends sake. From an investment standpoint, if it doesn't work in the tests, we could benefit with the other types of stem cells we store.
Talking about Embryonic Stem Cells below!
"We desperately need to know how these cells are going to perform in the human setting," said John Gearhart, a stem cell pioneer at the University of Pennsylvania.
The Food and Drug Administration has demanded extensive experiments in the laboratory and on animals to provide evidence that the cells are safe enough to test in people and hold great promise.
"If we're right, we'll revolutionize the treatment of many chronic diseases," said Thomas Okarma, president and chief executive of Geron Corp. of Menlo Park, Calif., which after years of delay received a green light in July from the FDA to study patients partially paralyzed by spinal cord injuries.
But some researchers fear that if patients are hurt by the cells -- or even if there's no hint that the cells help -- that could be a devastating blow just as scientists are scrambling for funding from private foundations and benefactors.
Market Data 
Markets 
AI
